Koninklijke Philips | PHG - Equity Capital And Reserves



Koninklijke Philips reported EUR10.41B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
Danaher USD 52.33B 1.48B Jun/2025
Demant DKK 9.4B 168M Jun/2025
Dexcom USD 2.57B 306.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Fresenius EUR 18.94B 465M Jun/2025
General Electric Aerospace USD 19.14B 116M Jun/2025
Getinge SEK 33.01B 2.75B Dec/2024
Globus Medical USD 4.3B 207.61M Jun/2025
GN Store Nord DKK 10.45B 304M Jun/2025
Hitachi JPY 5.82T 31.52B Jun/2025
Hologic USD 4.84B 223.8M Jun/2025
Idexx Laboratories USD -4410277000 5.86B Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Koninklijke Philips EUR 10.41B 1.6B Jun/2025
Masimo USD 1.04B 96.4M Jun/2025
Medtronic USD 48.02B 1.36B Apr/2025
Philips EUR 10.38B 1.32B Jun/2025
ResMed USD 5.97B 421.73M Jun/2025
Smith & Nephew USD 5.54B 271M Jun/2025
Steris USD 6.96B 341.24M Jun/2025
Stryker USD 21.19B 261M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Terumo JPY 1.37T 536M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025